[1] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3):209-220. [2] Tu WJ, Hua Y, Yan F, et al.Prevalence of stroke in China, 2013-2019: A population-based study[J]. Lancet Reg Health Western Pa, 2022, 18:1058-1066. [3] Popiela TJ, Krzyściak W, Pilato F, et al.The assessment of endovascular therapies in ischemic stroke: Management, problems and future approaches[J]. J Clin Med, 2022, 11(7):1864. [4] Choi EY, Nieves GA, Jones DE.Acute stroke diagnosis[J]. Am Fam Physician, 2022, 105:616-624. [5] Zhang J, Yuan T, Wei S, et al.New strategy for clinical etiologic diagnosis of acute ischemic stroke and blood biomarker discovery based on machine learning[J]. J RSC Adv, 2022, 12:14716-14723. [6] Sun C, Li X, Song B, et al.A NADE nomogram to predict the probability of 6-month unfavorable outcome in Chinese patients with ischemic stroke[J]. BMC Neurol, 2019,19(1):274. [7] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9):666-682. [8] World Health Organization.Guidelines for controlling and monitoring the tobacco epidemic[M]. Geneva: World Health Organization, 1998:76-77. [9] World Health Organization.Global status report on alcohol and health 2014[M]. Geneva: World Health Organization, 2014:4. [10] Meyer BC, Hemmen TM, Jackson CM, et al.Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: Prospective reliability and validity[J]. Stroke, 2002, 33(5):1261-1266. [11] 张世洪, 吴波, 谈颂. 卒中登记研究中Barthel指数和改良的 Rankin量表的适用性与相关性研究[J]. 中国循证医学杂志,2004,4(12):871-874. [12] 赵楠楠, 郑印, 黄穹琼, 等. 急性缺血性脑卒中早期预后不良的危险因素分析及预测模型构建[J]. 中国临床研究, 2022, 35(4):456-461. [13] 郝美美, 陈晨, 袁兴运, 等. 尿酸与急性缺血性脑卒中早期预后关系的研究[J]. 中华老年心脑血管病杂志, 2019, 21(5):515-518. [14] 杜秋明, 曹书华, 苏玫, 等. 不同年龄和性别脑卒中患者危险因素及预后[J]. 中国老年学杂志, 2021, 41(7):1374-1377. [15] 刘仲仲, 蔺雪梅, 段康丽, 等. 西安地区伴心房颤动老年急性缺血性卒中患者临床特征及1年预后分析[J]. 中国卒中杂志, 2019, 14(6):578-584. [16] 黄信全, 黄年平. 血管生成素1与急性缺血性脑卒中患者短期预后的相关性[J].心脑血管病防治, 2020, 20(2):176-178,197. [17] 赵晓晶, 李群喜, 刘英, 等. 美国国立卫生院脑卒中量表评分与脑出血患者预后的相关性探讨[J]. 中国临床医生杂志, 2019, 47(6):712-714. [18] Macrez R, Ali C, Toutirais O, et al.Stroke and the immune system: From pathophysiology to new therapeutic strategies[J]. Lancet Neurol, 2011, 10: 471-480. [19] Neuberger U, Möhlenbruch MA, Herweh C, et al.Classification of bleeding events: Comparison of ECASS III (European Cooperative Acute Stroke Study) and the new heidelberg bleeding classification[J]. Stroke, 2017, 48(7):1983-1985. [20] Nakamura A, Otani K, Shichita T.Lipid mediators and sterile inflammation in ischemic stroke[J]. Int Immunol, 2020, 32:719-725. [21] Nam KW, Jung KT, Sung LJ, et al.High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia[J]. Stroke, 2018, 49:1886-1892. [22] Zhang P, Wang C, Wu J, et al.A systematic review of the predictive value of plasma D-dimer levels for predicting stroke outcome[J]. Front Neurol, 2021, 12:693524. [23] Yuan B, Yang T, Yan T, et al.Relationships between D-dimer levels and stroke risk as well as adverse clinical outcomes after acute ischemic stroke or transient ischemic attack:A systematic review and meta-analysis[J]. Front Neurol, 2021, 12: 670730. [24] 芦军, 赵伟丽, 李国丽, 等.急性脑梗死患者血尿酸水平变化对近期和远期预后的影响[J]. 中国卫生标准管理, 2020, 11(5):31-33. |